Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Probuphine begins phase III trial for treatment of opioid dependence

Oct. 30, 2006

Sazetidine-A: a new desensitizing nicotinic ligand

Oct. 26, 2006

Novel sigma receptor antagonists combat cocaine-induced behavioral toxicity

Oct. 23, 2006

Desoxypeganine shows good pharmacokinetic profile in healthy volunteers

Oct. 11, 2006

Lofexidine studied for treatment of opiate withdrawal symptoms in phase III trial

Oct. 11, 2006

European approval for Suboxone for treatment of opioid dependence

Oct. 6, 2006

Alkermes developing oral products for treatment of addiction

Oct. 5, 2006

Champix approved in Europe

Oct. 2, 2006

PharmAthene awarded Department of Defense contract for Protexia development

Sep. 27, 2006

ArmaGen receives grant to develop first nerve gas antidote

Sep. 20, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...